BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 10717235)

  • 1. Translocation and coamplification of loci from chromosome arms 8p and 11q in the MDA-MB-175 mammary carcinoma cell line.
    Adélaïde J; Chaffanet M; Mozziconacci MJ; Popovici C; Conte N; Fernandez F; Sobol H; Jacquemier J; Pébusque M; Ron D; Lafage-Pochitaloff M; Birnbaum D
    Int J Oncol; 2000 Apr; 16(4):683-8. PubMed ID: 10717235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CCND1 and FGFR1 coamplification results in the colocalization of 11q13 and 8p12 sequences in breast tumor nuclei.
    Bautista S; Theillet C
    Genes Chromosomes Cancer; 1998 Aug; 22(4):268-77. PubMed ID: 9669664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. gamma-heregulin is the product of a chromosomal translocation fusing the DOC4 and HGL/NRG1 genes in the MDA-MB-175 breast cancer cell line.
    Wang XZ; Jolicoeur EM; Conte N; Chaffanet M; Zhang Y; Mozziconacci MJ; Feiner H; Birnbaum D; Pébusque MJ; Ron D
    Oncogene; 1999 Oct; 18(41):5718-21. PubMed ID: 10523851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Co-amplification of 8p12 and 11q13 in breast cancers is not the result of a single genomic event.
    Paterson AL; Pole JC; Blood KA; Garcia MJ; Cooke SL; Teschendorff AE; Wang Y; Chin SF; Ylstra B; Caldas C; Edwards PA
    Genes Chromosomes Cancer; 2007 May; 46(5):427-39. PubMed ID: 17285574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-resolution genomic analysis of the 11q13 amplicon in breast cancers identifies synergy with 8p12 amplification, involving the mTOR targets S6K2 and 4EBP1.
    Karlsson E; Waltersson MA; Bostner J; Pérez-Tenorio G; Olsson B; Hallbeck AL; Stål O
    Genes Chromosomes Cancer; 2011 Oct; 50(10):775-87. PubMed ID: 21748818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequency, prognostic impact, and subtype association of 8p12, 8q24, 11q13, 12p13, 17q12, and 20q13 amplifications in breast cancers.
    Letessier A; Sircoulomb F; Ginestier C; Cervera N; Monville F; Gelsi-Boyer V; Esterni B; Geneix J; Finetti P; Zemmour C; Viens P; Charafe-Jauffret E; Jacquemier J; Birnbaum D; Chaffanet M
    BMC Cancer; 2006 Oct; 6():245. PubMed ID: 17040570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fusion and amplification of two originally non-syntenic chromosomal regions in a mammary carcinoma cell line.
    Lafage M; Pedeutour F; Marchetto S; Simonetti J; Prosperi MT; Gaudray P; Birnbaum D
    Genes Chromosomes Cancer; 1992 Jul; 5(1):40-9. PubMed ID: 1384661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gamma-heregulin: a fusion gene of DOC-4 and neuregulin-1 derived from a chromosome translocation.
    Liu X; Baker E; Eyre HJ; Sutherland GR; Zhou M
    Oncogene; 1999 Nov; 18(50):7110-4. PubMed ID: 10597312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chromosome translocations in breast cancer with breakpoints at 8p12.
    Courtay-Cahen C; Morris JS; Edwards PA
    Genomics; 2000 May; 66(1):15-25. PubMed ID: 10843800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Co-amplified genes at 8p12 and 11q13 in breast tumors cooperate with two major pathways in oncogenesis.
    Kwek SS; Roy R; Zhou H; Climent J; Martinez-Climent JA; Fridlyand J; Albertson DG
    Oncogene; 2009 Apr; 28(17):1892-903. PubMed ID: 19330026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-resolution analysis of chromosome rearrangements on 8p in breast, colon and pancreatic cancer reveals a complex pattern of loss, gain and translocation.
    Pole JC; Courtay-Cahen C; Garcia MJ; Blood KA; Cooke SL; Alsop AE; Tse DM; Caldas C; Edwards PA
    Oncogene; 2006 Sep; 25(41):5693-706. PubMed ID: 16636668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A recurrent chromosome translocation breakpoint in breast and pancreatic cancer cell lines targets the neuregulin/NRG1 gene.
    Adélaïde J; Huang HE; Murati A; Alsop AE; Orsetti B; Mozziconacci MJ; Popovici C; Ginestier C; Letessier A; Basset C; Courtay-Cahen C; Jacquemier J; Theillet C; Birnbaum D; Edwards PA; Chaffanet M
    Genes Chromosomes Cancer; 2003 Aug; 37(4):333-45. PubMed ID: 12800145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural heterogeneity of hsr(11) in the MDA-MB-134 mammary carcinoma cell line.
    Lemieux N; Apiou F; Vogt N; Malfoy B; Dutrillaux B
    Cancer Genet Cytogenet; 1996 Aug; 90(1):75-9. PubMed ID: 8780752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The 11q13 amplicon of a mammary carcinoma cell line.
    Lafage M; Nguyen C; Szepetowski P; Pébusque MJ; Simonetti J; Courtois G; Gaudray P; deLapeyriere O; Jordan B; Birnbaum D
    Genes Chromosomes Cancer; 1990 Sep; 2(3):171-81. PubMed ID: 2078507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chromosome 11q13, c-erbB-2, and c-myc amplification in invasive breast carcinoma: clinicopathologic correlations.
    Gaffey MJ; Frierson HF; Williams ME
    Mod Pathol; 1993 Nov; 6(6):654-9. PubMed ID: 7905628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterisation of amplification patterns and target genes at chromosome 11q13 in CCND1-amplified sporadic and familial breast tumours.
    Holm K; Staaf J; Jönsson G; Vallon-Christersson J; Gunnarsson H; Arason A; Magnusson L; Barkardottir RB; Hegardt C; Ringnér M; Borg A
    Breast Cancer Res Treat; 2012 Jun; 133(2):583-94. PubMed ID: 22002566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene products of chromosome 11q and their association with CCND1 gene amplification and tamoxifen resistance in premenopausal breast cancer.
    Lundgren K; Holm K; Nordenskjöld B; Borg A; Landberg G
    Breast Cancer Res; 2008; 10(5):R81. PubMed ID: 18823530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NRG1 gene rearrangements in clinical breast cancer: identification of an adjacent novel amplicon associated with poor prognosis.
    Prentice LM; Shadeo A; Lestou VS; Miller MA; deLeeuw RJ; Makretsov N; Turbin D; Brown LA; Macpherson N; Yorida E; Cheang MC; Bentley J; Chia S; Nielsen TO; Gilks CB; Lam W; Huntsman DG
    Oncogene; 2005 Nov; 24(49):7281-9. PubMed ID: 16027731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FGFR1 emerges as a potential therapeutic target for lobular breast carcinomas.
    Reis-Filho JS; Simpson PT; Turner NC; Lambros MB; Jones C; Mackay A; Grigoriadis A; Sarrio D; Savage K; Dexter T; Iravani M; Fenwick K; Weber B; Hardisson D; Schmitt FC; Palacios J; Lakhani SR; Ashworth A
    Clin Cancer Res; 2006 Nov; 12(22):6652-62. PubMed ID: 17121884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-resolution array CGH clarifies events occurring on 8p in carcinogenesis.
    Cooke SL; Pole JC; Chin SF; Ellis IO; Caldas C; Edwards PA
    BMC Cancer; 2008 Oct; 8():288. PubMed ID: 18840272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.